Atlas Trials

Refractory Nodal Marginal Zone Lymphoma

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Nodal Marginal Zone Lymphoma

RecordFirmDate
Acalabrutinib and Duvelisib for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (NCT04836832)Narendranath Epperla2022-07-01
Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer (NCT03432741)Mayo Clinic2018-03-27
Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas (NCT02332980)Mayo Clinic2015-02-19

Track Refractory Nodal Marginal Zone Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.